The Use of Herbal Remedies among Mothers of Young Children Living in the Central Appalachian Region.
Monira Alwhaibi et al. (2017) · Evidence-based complementary and alternative medicine : eCAM
This cross-sectional survey of 178 mothers of young children in the Central Appalachian Region of the United States explored how many use herbal remedies and which factors are linked to that use. Herbal remedies are plant-based products taken for health purposes, and they are the most common form of complementary and alternative medicine (CAM, health approaches used alongside or instead of conventional care) among American adults. The authors framed the work with the Comprehensive Model of Information Seeking, which holds that a person's background, past experiences, mood and beliefs shape where information is sought and, in turn, whether action follows, here the use of herbal remedies.
The participants were women aged 18 or older with at least one child under three years of age, living in Central Appalachia and mostly in West Virginia, with a mean age of 31.3 years. They were recruited through social media groups, listserv emails, daycares and physician's offices, and completed an online survey. One item asked whether any herbal remedy had been used in the past six months, with follow-ups on which remedy and which condition. Two new five-point scales captured how often six information sources were used and how strongly herbal remedies were believed to be safe and effective.
One-third of the women (33.5%) reported using herbal remedies in the past six months. Fenugreek was the most widely used remedy (35.1%), followed by honey (8.8%), chamomile (5.3%) and ginger (5.3%). The main reasons were stimulating or increasing breast milk production (38.6%) and treating cold or flu symptoms (26.3%). Women with the highest information seeking scores had 3.61 times the odds of using herbal remedies compared with those with the lowest (95% CI 1.433-9.77), meaning that more active information seeking went with more use. Women with the highest belief in herbal safety and efficacy had 4.02 times the odds (95% CI 1.468-9.57). Part-time or unemployed women had 2.98 times the odds of full-time employed women (95% CI 1.05-8.47), while education, income and Appalachian identity showed no association. The internet was the most frequently used information source (mean 3.2 out of 5).
The authors conclude that herbal remedy use is common in this region and propose that public health efforts and communication from health care providers could raise awareness of the safety and efficacy of herbal remedies. The survey recorded use and beliefs only; it did not test whether any remedy worked, and safety was not assessed. Limitations include a sample drawn mostly from West Virginia, self-selection in an internet-based survey, self-reported answers open to recall bias, and no data on whether use was regular or occasional. The authors call for further research, including qualitative work, on what health information women seek.
Polycystic ovaries and herbal remedies: A systematic review.
Aliasghar Manouchehri et al. (2023) · JBRA assisted reproduction
Polycystic ovary syndrome (PCOS) is one of the most common hormone-related conditions affecting women of reproductive age, estimated to affect 4-25% of women depending on how it is diagnosed (14.6% in Iran). Beyond irregular periods and fertility struggles, PCOS often comes with insulin resistance, weight gain, acne, excess hair growth, and long-term metabolic risk. Because standard medications can carry side effects, researchers have looked to medicinal plants as gentler options. This review pulls together what is known about nine herbs -- from aloe vera to flax -- and how each is thought to act on the hormonal and metabolic disruptions behind PCOS.
Unlike a systematic review with a registered search protocol, this is a narrative synthesis: the authors describe the proposed mechanism of each of nine plants -- aloe vera, chamomile, chaste tree, cinnamon, ginseng, stachys, fennel, liquorice, and flax -- based mainly on animal and laboratory studies rather than human clinical trials. Each plant's key active compound and hypothesized mechanism of action are summarized in a comparison table, covering effects on hormone levels, ovarian tissue, insulin sensitivity, and inflammation.
Each herb is proposed to work differently. Cinnamon appears to improve insulin sensitivity and lower blood sugar and lipids by affecting insulin-receptor signaling. Chaste tree and fennel are proposed to shift the balance of reproductive hormones (chaste tree lowering testosterone, fennel raising progesterone and thickening the uterine lining). Flax's lignans are linked to lower androgen levels and less excess hair growth (hirsutism), while stachys is proposed to ease abnormal uterine bleeding by damping estrogen receptor activity. Chamomile and aloe vera are described as supportive of ovarian tissue and follicle development, and ginseng and liquorice are framed around broader immune and metabolic support. Importantly, the review does not report clinical trial results, statistics, or human outcome data for any of these plants -- the mechanisms described come mainly from animal models and lab studies, not from testing in women with PCOS.
The authors see herbal medicine as a promising, low-side-effect complement to PCOS care, working mainly through immune support and cycle regulation rather than direct hormone replacement -- but they are careful to say more research time is needed. Because this is a synthesis of mostly preclinical and mechanistic findings, none of these nine plants can be considered proven PCOS treatments; each is better read as a lead for future controlled human trials than as an established remedy to try in place of medical care.
Effects of chamomile and -theanine beverage on menstrual pain, menstrual symptoms, mood, and sleep quality in young women experiencing primary dysmenorrhea: A randomized, double-blind, placebo-controlled study.
Ziqing Soh et al. (2025) · Journal of food and drug analysis
This double-blind, randomized, placebo-controlled trial with 30 young Malaysian women explored whether a beverage combining chamomile and l-theanine could ease primary dysmenorrhea - menstrual cramping that occurs without any underlying pelvic disease. Chamomile (Matricaria recutita) is a flowering herb long used as a calming remedy; the study intervention used a standardized flower extract of it. L-theanine is a non-protein amino acid concentrated in tea leaves (Camellia sinensis), used in supplements to support relaxation. The trial paired both in a functional beverage (CTT) and tested it against a chamomile-flavored placebo (non-CTT) to see whether the combination eased pain, mood, and sleep during menstruation.
Thirty women aged 18-30 with primary dysmenorrhea (pain rated at least 4 of 10 on a visual scale across three cycles) were randomly split into a CTT group (480 mg chamomile extract plus 200 mg l-theanine daily) or a non-CTT control group, drinking two 240 mL packs daily - one on waking, one before bed - for five days spanning two days before their period through its third day. Pain was tracked with two 0-10 scales, symptoms with the 18-item Cox Menstrual Symptom Scale, sleep with the Pittsburgh Sleep Quality Index, and mood with the Profile of Mood States.
Compared to their own baseline, women drinking CTT saw pain scores drop by roughly 57% on both pain scales (p<0.001), a large reduction over five days. Eight menstrual symptoms also eased significantly, including lower abdominal pain (down 53%), back pain (down 56%), and irritability (down 45%, all p<0.05). Mood shifted too: depression scores fell 12% and vigor (energy and alertness) rose 62% (p<0.05). On sleep, only "daytime dysfunction" - grogginess, poor concentration, and low energy during the day - improved (down 32%, p<0.05); overall sleep quality, how long it took to fall asleep, and total sleep time did not change significantly. Hemoglobin levels, checked with a finger-prick test, were unaffected in either group, likely because red blood cells take weeks to months to regenerate, too slow to show up in five days. Interestingly, the placebo group also felt calmer on a few measures, which the researchers link to the shared chamomile scent and flavor rather than to any active ingredient.
For young women managing primary dysmenorrhea without relying on NSAIDs, a short course of this chamomile-l-theanine beverage appears to meaningfully ease pain and several physical and emotional symptoms, with no reported side effects. Because chamomile and l-theanine were only tested together, it is not yet clear how much each contributes individually, and the tiny sample (15 per group) and single five-day cycle mean the results are preliminary. Longer trials spanning multiple cycles, larger and more diverse groups, and a scent-neutral placebo are needed before firmer conclusions can be drawn.